Lombard Odier Asset Management (USA)’s Idexx Laboratories IDXX Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-463	Closed	-$296K	–	325
2025 Q3	$296K	Buy	+463	New	+$281K	0.02%	363
2023 Q2	–	Sell	-500	Closed	-$250K	–	395
2023 Q1	$250K	Sell	500 -300	-38%	-$144K	0.01%	262
2022 Q4	$326K	Hold	800	–	–	0.01%	273
2022 Q3	$261K	Buy	+800	New	+$294K	0.01%	298
2022 Q2	–	Sell	-500	Closed	-$274K	–	398
2022 Q1	$274K	Buy	+500	New	+$263K	0.01%	248
2017 Q4	–	Sell	-35,000	Closed	-$5.44M	–	234
2017 Q3	$5.44M	Buy	+35,000	New	+$5.53M	0.39%	81

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s IDXX Position: Q4 2025 in Review

Lombard Odier Asset Management (USA) sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 463 shares — an estimated $296K sold.

Lombard Odier Asset Management (USA) first reported a position in IDXX in Q3 2017 and held it in 6 quarters. The position peaked at $5.44M in Q3 2017. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

Lombard Odier Asset Management (USA) reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 463 Idexx Laboratories shares in Q4 2025, an estimated $296K.
Lombard Odier Asset Management (USA) first reported a position in Idexx Laboratories in Q3 2017 and held it in 6 quarters.
Lombard Odier Asset Management (USA)'s Idexx Laboratories position peaked at $5.44M in Q3 2017.
1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2025, filed 17 Feb 2026.